Pharmacovigilance Proton Pump Inhibitor Use Is Not Associated With Cardiac Arrhythmia in Critically Ill Patients

First Page		Document Content
Date: 2015-10-22 17:44:44 Cardiac arrhythmia Electrolyte disturbances Magnesium RTT Hypomagnesemia Nephrology Ventricular tachycardia Proton-pump inhibitor Antiarrhythmic agent Magnesemia Premature atrial contraction Supraventricular tachycardia		Pharmacovigilance Proton Pump Inhibitor Use Is Not Associated With Cardiac Arrhythmia in Critically Ill Patients Add to Reading List Source URL: lcp.mit.edu Download Document from Source Website File Size: 291,11 KB Share Document on Facebook

	Impella Assisted Cesarean Delivery in aWeeks Gestation 30 Year Old Female with Newly Diagnosed Cardiomyopathy & Multifocal Incessant Ventricular Tachycardia DocID: 1v7Uk - View Document
	Simulation of the MCG Signal in a 2D Cardiac Tissue Sheet with Ischemia Ling Dai*, Yunliang Zang, Guofa Shou and Ling Xia Cardiovascular disease is one of the leading causes of death in the world. Ventricular tachycardia DocID: 1v3Ix - View Document
	CASE REPORT 185 Morphology-algorithm match in an ICD patient with atrial fibrillation DocID: 1qLZ8 - View Document
	Pharmacovigilance Proton Pump Inhibitor Use Is Not Associated With Cardiac Arrhythmia in Critically Ill Patients DocID: 1pozx - View Document
	monitoring amiodarone infusion amiodarone walmart. amiodarone halflife. pulmonary mass amiodarone amiodarone hydrochloride amiodarone foxglove poisoning amiodarone pulmonary toxicity risk factors. amiodarone lung disease DocID: 1p3sm - View Document